Cargando…

The Advantage of PET and CT Integration in Examination of Lung Tumors

Purpose. To evaluate the diagnosis value of integrated positron emission tomography and computed tomography (PET/CT) with lung masses, this study emphasized the correlation between tumor size and maximum standardized uptake value (SUVmax) in selected regions of interest (ROI) of lung masses. Materia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Guangming, Wang, Zhongqiu, Zhu, Hong, Chang, Linfeng, Chen, Yingxin, Wu, Jiang, Zhao, Yane
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233876/ https://www.ncbi.nlm.nih.gov/pubmed/18274652 http://dx.doi.org/10.1155/2007/17131

Ejemplares similares

Advantages of Combined PET-CT in Mediastinal Staging in Patients with Non-small Cell Lung Carcinoma
por: Beslic, Nermina, et al.
Publicado: (2016)

Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung
por: Stefani, Alessandro, et al.
Publicado: (2013)

The potential advantages and workflow challenges of long axial field of view PET/CT
por: Chen, Wei‐Ting J., et al.
Publicado: (2023)

Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung
por: Chong, Semin, et al.
Publicado: (2007)

A Nordic survey of CT doses in hybrid PET/CT and SPECT/CT examinations
por: Bebbington, Natalie A., et al.
Publicado: (2019)

Correlations Study Between (18)F-FDG PET/CT Metabolic Parameters Predicting Epidermal Growth Factor Receptor Mutation Status and Prognosis in Lung Adenocarcinoma
por: Yang, Bin, et al.
Publicado: (2019)

Advantages of CT nano-contrast agent in tumor diagnosis: A retrospective study
por: Zhou, Yong, et al.
Publicado: (2021)

Steroid responsive inflammatory myofibroblastic tumor of the lung evaluated by FDG PET/CT imaging
por: Jiang, James Yuheng, et al.
Publicado: (2022)

Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers
por: Jiang, Rifeng, et al.
Publicado: (2017)

Cumulative radiation doses from recurrent PET–CT examinations
por: Hosono, Makoto, et al.
Publicado: (2021)

Staging of lung cancer CT and PET
por: McLoud, Theresa C
Publicado: (2014)

PET/CT and interstitial lung disease
por: Sawamura, Marcio Valente Yamada, et al.
Publicado: (2022)

New PET/CT Features for the Evaluation of Tumor Response
por: Lu, Wei
Publicado: (2013)

Concomitant lung and gastroenteropancreatic neuroendocrine tumors and the value of gallium-68 PET/CT
por: Kaemmerer, Daniel, et al.
Publicado: (2011)

Value of (18)F-FDG PET/CT-Based Radiomics Nomogram to Predict Survival Outcomes and Guide Personalized Targeted Therapy in Lung Adenocarcinoma With EGFR Mutations
por: Yang, Bin, et al.
Publicado: (2020)

Sequential delayed [18 F]FDG PET/CT examinations in the pharynx
por: Pietrzak, Agata Karolina, et al.
Publicado: (2020)

PET/CT in the Staging of the Non-Small-Cell Lung Cancer
por: Chao, Fangfang, et al.
Publicado: (2012)

Advantages and Applications of Total-Body PET Scanning
por: Katal, Sanaz, et al.
Publicado: (2022)

PET/CT and the Response to Immunotherapy in Lung Cancer
por: Evangelista, Laura, et al.
Publicado: (2020)

FDG PET/CT in the Staging of Lung Cancer
por: Farsad, Mohsen
Publicado: (2020)

Predictive value of baseline metabolic tumor burden on (18)F-FDG PET/CT for brain metastases in patients with locally advanced non-small-cell lung cancer
por: Shang, Jingjie, et al.
Publicado: (2022)

Predicting response to radiotherapy in tumors with PET/CT: when and how?
por: Shen, Li-Fang, et al.
Publicado: (2020)

Diagnostic efficacy of PET/CT in bone tumors
por: Han, Songhui, et al.
Publicado: (2019)

Rubidium Uptake in Chest Tumors on PET/CT
por: Oldan, Jorge D., et al.
Publicado: (2022)

Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques
por: Zhu, Guangwen, et al.
Publicado: (2011)

Solitary Fibrous Tumor of the Prostate Shown on FAPI PET/CT
por: Yang, Tianshuo, et al.
Publicado: (2023)

Advantage of PET/CT in Target Delineation of MRI-negative Cervical Lymph Nodes In Intensity-Modulated Radiation Therapy Planning for Nasopharyngeal Carcinoma
por: Shen, Guanzhu, et al.
Publicado: (2017)

Examining the evolving utility of (18)FDG-PET/CT in breast cancer recurrence
por: Djassemi, Navid, et al.
Publicado: (2020)

Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
por: Cheebsumon, Patsuree, et al.
Publicado: (2012)

Integrated Small Animal PET/CT/RT with Onboard PET/CT Image Guidance for Preclinical Radiation Oncology Research
por: Cheng, Xinyi, et al.
Publicado: (2023)

Comparison of integrated PET/MRI with PET/CT in evaluation of endometrial cancer: a retrospective analysis of 81 cases
por: Bian, Li-hua, et al.
Publicado: (2019)

PET/CT imaging in lung cancer: indications and findings
por: Hochhegger, Bruno, et al.
Publicado: (2015)

Session: Evaluation of lung nodules: role of PET/CT
por: Bellomi, Massimo, et al.
Publicado: (2014)

Atypical metastatic lung cancer of the right ventricle on FDG PET/CT
por: Jiang, James Yuheng, et al.
Publicado: (2021)

PET-CT
Publicado: (2011)

Askin Tumor: CT and FDG-PET/CT Imaging Findings and Follow-Up
por: Xia, Tingting, et al.
Publicado: (2014)

Performance of (68)Ga-DOTA-SST PET/CT, octreoscan SPECT/CT and (18)F-FDG PET/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis
por: Jiang, Yuanyuan, et al.
Publicado: (2020)

The importance of PET/CT in the evaluation of patients with Ewing tumors
por: Guimarães, Júlio Brandão, et al.
Publicado: (2015)

Proliferation PET/CT Imaging of Salivary Gland Tumor
por: Minamimoto, Ryogo
Publicado: (2021)

FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors
por: Yang, Tianshuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bo2ksnie08rp5a37t2mju8o88v